Experiences with
Golimumab101 public posts
Want to take advantage of all our features? Just log in!
or
An indicator in the blood could guide lupus treatment
A clinical trial (called “BEAT-Lupus”) has found that using a combination of two biologic treatments, rituximab and belimumab, may be more effective than using rituximab alone in patients who have not responded well to other treatment. They also found that people with a particular indicator in their
SLE patients may have reduced response to COVID-19 vaccination
Some immunosuppressive treatments also have an effect, study finds
by Andrea Lobo, PhD | February 23, 2023
Patients with systemic lupus erythematosus (SLE) have a reduced response to COVID-19 vaccination, an effect made worse by specific immunosuppressive treatments, a recent study reports.
A
SMC approve belimumab (Benlysta) for use by NHS Scotland
The Scottish Medicines Consortium (SMC) recently completed their assessment of belimumab (Benlysta) as a treatment for active auto-antibody positive systemic lupus erythematosus (SLE). We are pleased to report that they have recommended the treatment as an option to be added to standard therapy for
Treatments for Lupus May Reduce Response to COVID-19 Vaccination
Lower response to vaccination translates to a higher risk of COVID-19 infection
by Lindsey Shapiro | October 6, 2022
Antibodies mounted against COVID-19 in the three to six months following vaccination were lower in patients undergoing treatment for lupus than in healthy people, a study has